| dc.identifier.citation | Tresserra-Rimbau, A., Castro-Barquero, S., Vitelli-Storelli, F., Becerra-Tomas, N., Vázquez-Ruiz, Z., Díaz-López, A., ... & Alonso-Gómez, Á. M. (2019). Associations between Dietary Polyphenols and Type 2 Diabetes in a Cross-Sectional Analysis of the PREDIMED-Plus Trial: Role of Body Mass Index and Sex. Antioxidants, 8(11), 537. | es_ES |
| dc.description.abstract | Overweight and obesity are important risk factors for type 2 diabetes (T2D). Moving towards
healthier diets, namely, diets rich in bioactive compounds, could decrease the odds of suffering
T2D. However, those individuals with high body mass index (BMI) may have altered absorption
or metabolism of some nutrients and dietary components, including polyphenols. Therefore, we
aimed to assess whether high intakes of some classes of polyphenols are associated with T2D in a
population with metabolic syndrome and how these associations depend on BMI and sex. This baseline
cross-sectional analysis includes 6633 participants from the PREDIMED-Plus trial. Polyphenol intakes
were calculated from food frequency questionnaires (FFQ). Cox regression models with constant
time at risk and robust variance estimators were used to estimate the prevalence ratios (PRs) for polyphenol intake and T2D prevalence using the lowest quartile as the reference group. Analyses
were stratified by sex and BMI groups (overweight and obese) to evaluate potential effect modification.
Catechins, proanthocyanidins, hydroxybenzoic acids, and lignans were inversely associated with T2D.
Hydroxycinnamic acids were directly related in men. These associations were different depending on
sex and BMI, that is, women and overweight obtained stronger inverse associations. | es_ES |
| dc.description.sponsorship | The PREDIMED-Plus trial was supported by the official Spanish Institutions for funding scientific
biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) and Instituto de Salud
Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European
Regional Development Fund (four coordinated Fondo de Investigaciones Sanitarias projects leaded by J.S.-S. and
J.V., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233,
PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206,
PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873,
PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183,
PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, and
PI17/00926), the Especial Action Project entitled Implementación y evaluación de una intervención intensiva sobre
la actividad física Cohorte PREDIMED-Plus grant to J.S.-S., European Research Council (Advanced Research Grant
2014–2019, 340918) to M.Á.M.-G., the Recercaixa grant to J.S.-S. (2013ACUP00194), grants from the Consejería
de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, and PI0137/2018), a grant from the Generalitat
Valenciana (PROMETEO/2017/017), a SEMERGEN grant, a CICYT grant provided by the Ministerio de Ciencia,
Innovación y Universidades (AGL2016-75329-R), and funds from the European Regional Development Fund
(CB06/03). Food companies Hojiblanca (Lucena, Spain) and Patrimonio Comunal Olivarero (Madrid, Spain)
donated extra virgin olive oil, and the Almond Board of California (Modesto, CA, USA), American Pistachio
Growers (Fresno, CA, USA), and Paramount Farms (Wonderful Company, LLC, Los Angeles, CA, USA) donated
nuts. J.K. was supported by the “FOLIUM” program within the FUTURMed project entitled Talent for the medicine
within the future from the Fundació Institut d’Investigació Sanitària Illes Balears. This call was co-financed at 50%
with charge to the Operational Program FSE 2014-2020 of the Balearic Islands. | es_ES |